Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Arcadia Biosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 25 | 22 | −3 |
| Shares | 1.92M | 1.71M | −211.6K (−11.0%) |
| Value | $2.69M | $1.71M | −$977.9K (−36.4%) |
New holders (3)
Institutions that held Arcadia Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 25,169 | $25.0K | 0.00% |
| StoneX Group Inc. | 13,136 | $13.1K | 0.00% |
| Harbour Investments, Inc. | 23 | $0 | 0.00% |
Sold out (6)
Institutions that held Arcadia Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Jane Street Group, LLC | 36,458 | $51.0K |
| Squarepoint Ops LLC | 19,403 | $27.0K |
| XTX Topco Ltd | 12,396 | $17.0K |
| Citigroup Inc | 8,150 | $11.0K |
| UBS Group AG | 4,561 | $6.00K |
| Bedel Financial Consulting, Inc. | 1,845 | $3.00K |